Results 181 to 190 of about 6,598 (226)

Hitting the Sweet Spot: The Impact of Elexacaftor/Tezacaftor/Ivacaftor on Glucose Tolerance in Cystic Fibrosis. [PDF]

Am J Respir Crit Care Med
Douglas TA, McMahon SK, Wainwright CE.
europepmc   +1 more source

UAB clinical trials pave way to new cystic fibrosis drug [PDF]

, 2017
Staff,
core   +1 more source

Case Series on the Combined Therapy with Elexacaftor/Tezacaftor/Ivacaftor During Pregnancy in Women with Severe Cystic Fibrosis: A Retrospective Report from an Italian Centre. [PDF]

J Clin Med
Iacotucci P, Somma J, Ferrillo L, Celardo A, Conti V, Carlo CD, Rengo G, Corbi G, Carnovale V.   +8 more
europepmc   +1 more source

Supplementary material from "A QbD-Guided, Eco-Friendly UHPLC Method for Simultaneous Estimation of Tezacaftor and Ivacaftor: A Stability-Indicating and Green Analytical Approach"

Hashmi, Shadab Anwar, Pelimelli, Navya Sahithi, Thota, Jagadeshwar Reddy, Pallavi, Alegete   +3 more
openalex   +1 more source

Effects of CFTR Modulators on <i>Pseudomonas aeruginosa</i> Infections in Cystic Fibrosis. [PDF]

Infect Dis Rep
Pescaru CC, Crișan AF, Marițescu A, Cărunta V, Marc M, Dumitrache-Rujinski Ș, Laitin S, Oancea C.   +7 more
europepmc   +1 more source

Understanding Pharmacokinetic-Drug Interactions With Drugs Approved by the US Food and Drug Administration in 2024 to Better Manage the Risk of Drug Interactions With Concomitant Medications: A Review of Clinical Data From New Drug Applications. [PDF]

Curr Ther Res Clin Exp
Yu J, Argon S, Owens K, Wang Y, Ragueneau-Majlessi I.   +4 more
europepmc   +1 more source

RFFL antisense oligonucleotides: A novel stabilization strategy to broaden the reach of CFTR modulator therapy. [PDF]

Mol Ther Nucleic Acids
Pedemonte N.
europepmc   +1 more source

Phosphatidylinositol 5-Phosphate-Loaded Apoptotic Body-Like Liposomes for Mycobacterium abscessus Infection Management in Patients With Cystic Fibrosis. [PDF]

J Infect Dis
Olimpieri T, Poerio N, Saliu F, Lorè NI, Ciciriello F, Ponsecchi G, D'Andrea MM, Alghisi F, Cirillo DM, Fraziano M.   +9 more
europepmc   +1 more source

Impact of elexacaftor/tezacaftor/ivacaftor on the small airways in cystic fibrosis. [PDF]

J Bras Pneumol
Silva SC, Barroso A, Cunha M, Fragoso E, Azevedo P.   +4 more
europepmc   +1 more source

Decreased insulin dose-adjusted hemoglobin A1c in adults with cystic fibrosis-related diabetes treated with elexacaftor-tezacaftor-ivacaftor. [PDF]

J Clin Transl Endocrinol
Burnet E, Grunewald D, Larger E, Camus-Bablon F, Eisenhauer C, Mifsud F, Martin C, Honoré I, Kanaan R, Carlier N, Fesenbeckh J, Mosnier-Pudar H, Burgel PR.   +12 more
europepmc   +1 more source